• The New Obesity Drugs: What Cardiac Practitioners Need to Know

  • Mar 19 2024
  • Length: 35 mins
  • Podcast

The New Obesity Drugs: What Cardiac Practitioners Need to Know

Listen for free

View show details

  • Summary


  • Please join our special guest Dr. Ian Neeland from University Hospitals in Cleveland, to discuss the intersection of obesity and cardiovascular disease, and specifically the roles of the new agents semaglutide and tirzepatide. We discuss the recent data on cardiovascular outcomes with these agents, assessing patient candidacy, and tips for initiating and monitoring therapy. We also reviewed the complementary role of bariatric surgery and pharmacotherapy to improve cardiac outcomes.

    For more information, see the SELECT study.
    For more information about the UH CINEMA program, click on this link.

    Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.

    “Upbeat Party” by scottholmesmusic.com
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The New Obesity Drugs: What Cardiac Practitioners Need to Know

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available